FindTrial
Sign In

preperitoneal analgesia in Cesarean Section

Preperitoneal post-cesarean section bupivacaine analgesia: Comparison between dexamethasone and dexmedetomidine as adjuvants.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201701002007277
Enrollment
Unknown
Registered
2017-01-30
Start date
2016-04-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section

Interventions

Dexmedetomidine Group
Dexamethasone. Group

Sponsors

mansoura university hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients scheduled for elective CS under general anesthesia. Including: different parity, presentation, body mass index (BMI) ASA status I-II.

Exclusion criteria

Exclusion criteria: 1. Patient refusal. 2. Patients with relevant drug allergy. 3. Pre-eclampsia and eclampsia. 4. History of drug abuse. 5. Patients with psychiatric disorders. 6. Local area infection. 7. Inability for peritoneal closure. 8. Inability of communication. 9. Hepatic, renal, respiratory, cardiac impairments

Design outcomes

Primary

MeasureTime frame
The time to first request of analgesia—

Secondary

MeasureTime frame
pain assessment by NRS;Ketorolac consumption ;Nalbuphine consumption ;Mean arterial pressure;Heart Rate;The cost of analgesic drugs.;The number of preperitoneal injections;Side effects (nausea, vomiting, pruritus and sedation);Anti emetic utilization (metoclopramide 10 mg, ondansterone 4 mg );incidence of Wound infection. ;patient satisfaction in a score 0-10—

Countries

Egypt

Contacts

Public ContactAlaa Mazy

associate profesor of anesthesia and surgical intensive care

alaa_mazy@yahoo.com002050 01140065052

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026